A novel il-15r alpha fc fusion protein and uses thereof
AssigneeStaidson Biopharma Inc.
InventorsYong YIN, Wenwu ZHAI
Life of this patent
Estimating the term…
Abstract
The present application relates to IL-15Rα and Fc fusion protein, IL-15 and IL-15Rα heterodimeric protein, and isolated nucleic acid molecule encoding any of the fusion protein or the heterodimeric protein, vectors and host cells comprising such nucleic acid molecule, compositions, kits, and articles of manufacture comprising any of the fusion protein or the heterodimeric protein, and methods of making, and using thereof.
Claims22
1-23. (canceled)
A method of improving the activity of a fusion protein or a heterodimeric protein comprising IL-15Rα or a functional fragment thereof and Fc domain, wherein, the peptide linker connecting the IL-15Rα or a functional fragment thereof and the Fc domain was set and the length of the peptide linker was more than 15 and less than 40 amino acid residues.
27-34. (canceled)
Dependencies are inferred from the claim text.